S1-nuclease mapping of the genomic Lepore-Boston DNA demonstrates that the entire large intervening sequence of the fusion gene is of beta-type.

Y. Chebloune,D. Poncet,G. Verdier

DOI: https://doi.org/10.1016/0006-291X(84)91421-9

1984-04-16

Abstract:

What problem does this paper attempt to address?

Correlation Between Hashimoto's Thyroiditis–Related Thyroid Hormone Levels and 25-Hydroxyvitamin D

Guanqun Chao,Yue Zhu,Lizheng Fang

DOI: https://doi.org/10.3389/fendo.2020.00004

IF: 6.055

2020-01-01

Frontiers in Endocrinology

Abstract:Objective: The purpose of this study was to further clarify the association of Hashimoto's thyroiditis (HT) and vitamin D deficiency, and to seek the connection between them and related influencing factors.Methods: Data were obtained from subjects who underwent health examinations from January 2018 to December 2018. The diagnosis of HT was based on: antithyroid peroxidase antibody (TPO-Ab) levels >35 IU/ml and/or antithyroglobulin antibody (Tg-Ab) levels >40 IU/ml. Based on the Endocrine Society guidelines, 25-hydroxyvitamin D [25(OH)D] levels ≥30.0 ng/ml were classified as a vitamin D sufficiency; those between 20 and 29.9 ng/ml, as an insufficiency; and those <20 ng/ml, as a deficiency. All statistical analysis was performed by software R.Results: Of a total of 75,436 individuals who were physically examined, 5,656 of them had 25(OH)D levels tested at the same time; 5,230 were enrolled. The level of 25(OH)D in the non-HT group was higher than that in the HT group. Multiple regression analysis showed that HT was statistically significantly correlated with being male, body mass index (BMI), waist circumference, and thyroid-stimulating hormone (TSH). TSH levels in the insufficiency group and deficiency group were higher than those in the sufficiency group. Free triiodothyronine (FT3) and thyroxine (FT4) levels in the insufficiency group and deficiency group were lower than those in the sufficiency group. 25(OH)D increased by 1 ng/ml at the normal reference level, with an increase of 2.78 ng/dl in FT4 concentration and a decrease of 0.17 mIU/L in TSH.Conclusions: Patients with HT present with a reduced 25(OH)D level, and TSH is an independent risk factor for HT. TSH is negatively correlated with 25(OH)D level. FT3 and FT4 levels were positively correlated with 25(OH)D levels.
Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto’s Thyroiditis? A Double Blind, Randomized Clinical Trial

Reza Chahardoli,Ali-Akbar Saboor-Yaraghi,Atieh Amouzegar,Davood Khalili,Azita Vakili,Fereidoun Azizi

DOI: https://doi.org/10.1055/a-0856-1044

2019-05-01

Hormone and Metabolic Research

Abstract:Abstract Hashimoto’s thyroiditis (HT) is the most prevalent autoimmune disorder characterized by the destruction of thyroid cells caused by leukocytes and antibody-mediated immune processes accompanied by hypothyroidism. In recent years, evidence has emerged pointing to various roles for vitamin D, including, proliferation and differentiation of normal and cancer cells, cardiovascular function, and immunomodulation. Vitamin D deficiency has been especially demonstrated in HT patients. The aim of this study was to investigate the effect of vitamin D on circulating thyroid autoantibodies and thyroid hormones profile (T4, T3, and TSH) in females with HT. Forty-two women with HT disease were enrolled in this randomized clinical trial study and divided into vitamin D and placebo groups. Patients in the vitamin D and placebo groups received 50 000 IU vitamin D and placebo pearls, weekly for 3 months, respectively. The serum levels of 25-hydroxy vitamin D [25(OH) D], Ca++ion, anti-thyroperoxidase antibody (anti-TPO Ab), anti-thyroglobulin antibody (anti-Tg Ab), T4, T3, and TSH were measured at the baseline and at the end of the study using enzyme-linked immunosorbent assays. The results of this study showed a significant reduction of anti-Tg Ab and TSH hormone in the Vitamin D group compared to the start of the study; however, there was a no significant reduction of anti-TPO Ab in the Vitamin D group compared to the placebo group (p=0.08). No significant changes were observed in the serum levels of T3 and T4 hormones. Therefore, vitamin D supplementation can be helpful for alleviation of the disease activity in HT patients; however, further well controlled, large, longitudinal studies are needed to determine whether it can be introduced in clinical practice.

endocrinology & metabolism
Clinical Efficacy and Mechanism of Vitamin D2 in Treating Hashimoto's Thyroiditis

Lu Gan,Yuqi Li

DOI: https://doi.org/10.2147/jir.s441120

IF: 4.5

2024-02-22

Journal of Inflammation Research

Abstract:Lu Gan, Yuqi Li Department of Endocrinology, General Hospital of Ningxia Medical University, Yinchuan City, 750000, People's Republic of China Correspondence: Lu Gan, Ningxia Medical University General Hospital, 804 Shengli Street South Street, Yinchuan City, 750000, People's Republic of China, Tel +86-13709518674, Email Objective: Hashimoto's thyroiditis (HT) is one of the most common autoimmune diseases, with the highest incidence rate among autoimmune thyroid disorders. Vitamin D2 may have therapeutic effects on HT. This study aimed to elucidate the molecular mechanisms underlying vitamin D2 therapy for HT. Methods: Differentially expressed genes (DEGs) associated with vitamin D2-treated HT were identified, and the DEG-associated gene enrichment pathway was explored using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. The correlation between the hub genes and infiltrating immune cells was investigated, and the interactions among the hub genes and target drug and competing endogenous RNA (ceRNA; long non-coding RNA [lncRNA]–microRNA [miRNA]–messenger RNA [mRNA]) regulatory networks were determined. Results: GO and KEGG enrichment analyses identified a total of 102 DEGs (6 upregulated and 96 downregulated) in the vitamin D2-treated group samples. The area under the curve values of the identified 10 hub genes was as follows: CCR1(0.920), CXCL1 (0.960), CXCL8 (0.960), EGR1 (0.960), FCGR3B (0.920), FOS (1.000), FPR1 (0.840), MMP9 (0.720), PTGS2 (0.960), and TREM1 (1.000). The immune enrichment scores of the mast cell (P = 0.008), neutrophil (P = 0.016), and plasmacytoid dendritic cell (P = 0.016) were significantly decreased in the vitamin D2-treated group (P < 0.05). The hub gene/drug regulatory network included 8 hub genes, 108 molecular drugs, and 114 interaction relationship pairs. The ceRNA regulatory network included 129 lncRNAs, 145 miRNAs, mRNAs (hub genes), and 324 interaction relationship pairs. Conclusion: Vitamin D2 may play an immunomodulatory role by regulating the aforementioned immune-related molecules and immune cells, thereby improving its therapeutic effects on HT. Keywords: Hashimoto's thyroiditis, vitamin D2, RNA sequencing, differentially expressed genes, immune infiltration Hashimoto's thyroiditis (HT) is one of the most prevalent autoimmune diseases, with the highest incidence rate among autoimmune thyroid disorders. 1 Studies have revealed the annually increasing incidence of HT. In China, the prevalence of HT ranges from 0.2% to 1.3%. 2,3 HT pathology mainly includes diffuse lymphocyte and plasma cell infiltration, interstitial fibrosis, glandular atrophy, and acidic degeneration of follicles. 4 The onset of HT is indistinct; many patients are asymptomatic during the early stages, and the cardinal clinical feature is painless, diffuse goiter. Approximately half of the patients with HT develop hypothyroidism and require lifelong thyroid hormone replacement. The risk of papillary thyroid carcinoma in patients with HT is considerably higher than that in the general population. Furthermore, the presence of thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TGAb) may lead to unexplained infertility, abortion, preterm delivery, and postpartum thyroid disorders. 5 Therefore, the high incidence of HT confers immense burdens on patients, the families of patients, and society. Vitamin D2 (ergocalciferol) from foods and vitamin D3 (cholecalciferol) from sunlight exposure collectively constitute vitamin D. 6 Vitamin D further undergoes biotransformation into more biologically active metabolites. In the liver, vitamin D is hydroxylated by 25-hydroxylase into its major circulating form, 25-hydroxyvitamin D (25OHD). Thus, blood 25OHD levels reflect vitamin D status from both diet and sunlight exposure. 7 Numerous studies have confirmed associations between HT and trace elements such as iodine and selenium; 8–11 however, the association between HT and vitamin D remains debatable. A recent review proposed that vitamin D deficiency may contribute to the pathophysiology, hypothyroidism, and autoimmunity of HT. 12 Moreover, a randomized controlled trial showed that vitamin D supplementation benefits HT remission; newly diagnosed patients with HT were randomly assigned to either an intervention group receiving weekly supplementation of 60,000 IU of vitamin D3 and 500 mg/day of calcium for 8 weeks or a control group receiving only 500 mg/day of calcium. The results of the trial showed that after 3 months, TPOAb decreased by 46.73% in the intervention group, which is significantly more than the 16.6% decrease in the control group (P = 0.028). 13 Additionally, Musco -Abstract Truncated-

immunology
Association of vitamin D and inflammatory biomarkers with newly diagnosed cases of hypothyroidism- A case-control study

Ahmad N,Iqbal S,Ahmad M,Farooque I,Khatoon T,Gupta A,Ahmad T

DOI: https://doi.org/10.17727/jmsr.2024/12-29

2024-04-02

Journal of Medical and Scientific Research

Abstract:Background: Deranged thyroid hormones and TSH induces the release of inflammatory biomarkers and recent evidence has demonstrated an association between low vitamin D status and autoimmune thyroid diseases, but there is little documented evidence available about the association of vitamin D and inflammatory biomarkers. So, this study was planned to investigate the relationship between vitamin D and inflammatory biomarkers. Materials and Methods: This case-control study was carried out among 60 study participants (30 cases and 30 controls) in the Department of Biochemistry, F.H Medical College, its associated Hospital from January 2023 to June 2023 The samples were divided in to two groups, cases (hypothyroid patients) and healthy control group. Serum was separated by centrifuging blood at 3000 rpm for 10 mi. Estimation of CRP was done turbidimetric immune assay method. Statistical analysis was done by using the (SPSS) version 20.0. Pearson correlation and Student’s t-test was applied, p-value <0.0001 was taken as significance. Results: The (mean ±SD) CRP values in the subjects having hypothyroid disorder (cases) were 3.12± 0.79 mg/L and in control was 2.01±0.75 mg/L (p-value <0.0001). The weight was found to be higher in cases. The CRP and IL-6 had an insignificant correlation with the BMI (r=0.06, p=0.74) and (r=0.64, p=0.35) and also insignificant correlation was found in between the CRP and the blood pressure. Conclusion: This study concludes that CRP and IL-6 levels were significantly higher in hypothyroid patients and insignificant correlation was found between anthropometric measurements of hypothyroid patients and inflammatory biomarkers. Keywords: vitamin D; CRP; IL-6; hypothyroidism; hypothyroid patients
The Effect of Vitamin D Supplementation on Thyroid Hormone Levels in Patients With Autoimmune Thyroid Disease: A Systematic Review

Sabaa I Saad-Omer,Shivani Singh,Oluwatoba T Olayinka,Jaslin Orelus,Mah Rukh Nisar,Rudrani Kotha,Naiela E Almansouri

DOI: https://doi.org/10.7759/cureus.66062

2024-08-03

Cureus

Abstract:Autoimmune thyroid diseases (AITDs) pose significant challenges in clinical practice, representing one of the most common endocrine abnormalities. Vitamin D deficiency has been linked as one of the contributing factors to the etiology of AITDs. This systematic review evaluates the effects of vitamin D supplementation on thyroid-stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4) levels in adults with AITDs. Using a PICO (population, intervention, comparison, and outcome) framework and adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, seven relevant studies were identified from an initial pool of 1,469 articles. The population comprised individuals with thyroid autoimmunity, as evidenced by at least one elevated positive thyroid autoimmune marker and intervention involved the supplementation of vitamin D, regardless of the dose or method of administration. All randomized clinical trials within the last 10 years, which fit the study criteria, were included. These studies showed varying results based on follow-up duration. Short-term studies (three months or less) demonstrated no significant changes in mean TSH, T3, or T4 levels compared to the control group with vitamin D supplementation. However, all of the long-term studies (greater than three months) indicated significant improvements compared to the control in mean TSH, T3, and T4 levels. Additionally, all long-term studies that compared TSH, T3, and T4 to baseline levels revealed significant changes by the trial's end. Despite these promising findings, the review highlights limitations, including small sample sizes, short study durations, and the need for further research to establish optimal dosing and treatment duration for vitamin D in AITD management. The overall findings suggest that vitamin D supplementation may play a part in thyroid hormone regulation in AITD, particularly with prolonged administration.
Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey

Ravinder Goswami,Raman Kumar Marwaha,Nandita Gupta,Nikhil Tandon,Vishnubhatla Sreenivas,Neeraj Tomar,Debarti Ray,Ratnesh Kanwar,Rashmi Agarwal

DOI: https://doi.org/10.1017/S0007114509220824

Abstract:25-Hydroxy vitamin D (25(OH)D) deficiency is linked with predisposition to autoimmune type 1 diabetes and multiple sclerosis. Our objective was to assess the relationship between serum 25(OH)D levels and thyroid autoimmunity. Subjects included students, teachers and staff aged 16-60 years (total 642, 244 males, 398 females). Serum free thyroxine, thyroid-stimulating hormone (TSH), and thyroid peroxidase autoantibodies (TPOAb), intact parathyroid hormone and 25(OH)D were measured by electrochemiluminescence and RIA, respectively. Thyroid dysfunction was defined if (1) serum TSH > or = 5 microU/ml and TPOAb>34 IU/ml or (2) TSH > or = 10 microU/ml but normal TPOAb. The mean serum 25(OH)D of the study subjects was 17.5 (sd 10.2) nmol/l with 87 % having values < or = 25 nmol/l. TPOAb positivity was observed in 21 % of subjects. The relationship between 25(OH)D and TPOAb was assessed with and without controlling for age and showed significant inverse correlation (r - 0.08, P = 0.04) when adjusted for age. The prevalence of TPOAb and thyroid dysfunction were comparable between subjects stratified according to serum 25(OH)D into two groups either at cut-off of < or = 25 or >25 nmol/l or first and second tertiles. Serum 25(OH)D values show only weak inverse correlation with TPOAb titres. The presence of such weak association and narrow range of serum 25(OH)D did not allow us to interpret the present results in terms of quantitative cut-off values of serum 25(OH)D. Further studies in vitamin D-sufficient populations with wider range of serum 25(OH)D levels are required to substantiate the findings of the current study.
Alterations in CD4+ T Cell Cytokines Profile in Female Patients with Hashimoto’s Thyroiditis Following Vitamin D Supplementation: A Double-blind, Randomized Clinical Trial

Reza Chahardoli,Behrouz Robat-Jazi,Fereidoun Azizi,Atieh Amouzegar,Davood Khalili,Azita Zadeh-Vakili,Fatemeh Mansouri,Ali Akbar Saboor-Yaraghi

DOI: https://doi.org/10.2174/0118715303273297231226153751

2024-01-25

Abstract:Background: Hashimoto's thyroiditis (HT) is an autoimmune disease characterized by the destruction of thyroid cells through immune processes involving T helper (Th)1 cytokines. This clinical trial investigates the impact of vitamin D supplementation on serum cytokine levels and gene expression in CD4+ T cells from HT patients, aiming to understand its effects on Th-1, Th-2, Th-17, and regulatory T (Treg) cell-associated factors. Methods: Female patients were randomly assigned in a double-blind design to either a vitamin D-supplemented group, which received cholecalciferol [1, 25(OH)2D3] at a dose of 50,000 IU, or the placebo group, which received a weekly placebo for a duration of three months. Serum cytokine levels were assessed using enzyme-linked immunosorbent assay (ELISA), while genes’ expression levels were measured using real-time PCR. Results: Serum 25-hydroxyvitamin D and levels exhibited a significant increase following vitamin D supplementation, in comparison to the placebo group. Additionally, the vitamin D supplementation resulted in a significant elevation of serum calcium (Ca) levels compared to baseline. In the vitamin D group, there was a significant decrease in both serum levels and expression of the interleukin (IL)-17 gene when compared to baseline, although no statistical difference was observed between the placebo and vitamin D groups. The gene expression of transforming growth factor-beta (TGFβ) was significantly increased in the vitamin D group compared to baseline, with no significant difference between the two study groups. Vitamin D treatment had no effect on serum levels of interferon-gamma (IFNΥ) and IL-4. While the gene expression of IL-4 in the vitamin D group did not exhibit a statistically significant increase, the level of GATA3 transcription factor increased significantly when compared to the placebo group. The expression of IFNΥ and transcription factors, T-bet, RORc, and forkhead box protein 3 (FOXP3) in genes did not show significant changes following vitamin D supplementation. Conclusion: The findings suggest that vitamin D supplementation may hold potential benefits for autoimmune diseases, such as HT. However, further longitudinal clinical trials are necessary to gain a more comprehensive understanding of the specific effects of vitamin D on HT. Clinical Trial Registration Number: IRCT2016110130644N1.

pharmacology & pharmacy,immunology,endocrinology & metabolism
Autoimmune Thyroiditis and Vitamin D

Teodoro Durá-Travé,Fidel Gallinas-Victoriano

DOI: https://doi.org/10.3390/ijms25063154

IF: 5.6

2024-03-09

International Journal of Molecular Sciences

Abstract:Hashimoto's thyroiditis (HT) is marked by self-tissue destruction as a consequence of an alteration in the adaptive immune response that entails the evasion of immune regulation. Vitamin D carries out an immunomodulatory role that appears to promote immune tolerance. The aim of this study is to elaborate a narrative review of the relationship between vitamin D status and HT and the role of vitamin D supplementation in reducing HT risk by modulating the immune system. There is extensive literature confirming that vitamin D levels are significantly lower in HT patients compared to healthy people. On the other hand, after the supplementation with cholecalciferol in patients with HT and vitamin D deficiency, thyroid autoantibody titers decreased significantly. Further knowledge of the beneficial effects of vitamin D in the prevention and treatment of autoimmune thyroid diseases requires the execution of additional randomized, double-blind, placebo-controlled trials and longer follow-up periods.

biochemistry & molecular biology,chemistry, multidisciplinary
Assessment of Vitamin Concentrations in Patients with Hashimoto's Thyroiditis and Their Relationships with Thyroid Function, Biochemical Status, and Anthropometric Parameters—A Preliminary Study

Aniceta Ada Mikulska-Sauermann,Matylda Resztak,Marta Karaźniewicz-Łada,Dorota Filipowicz,Marek Ruchała,Franciszek K. Główka

DOI: https://doi.org/10.3390/nu16111694

IF: 5.9

2024-05-30

Nutrients

Abstract:Hashimoto's thyroiditis (HT) is the leading cause of hypothyroidism, affecting mainly the female population. Many patients with HT have metabolic disorders and nutritional deficiencies. The aim of this study was to evaluate vitamin D, A, E, B2, and B6 concentrations, thyroid function, metabolic profile, and anthropometric parameters of patients with Hashimoto's thyroiditis. In 81 female patients with HT (study group), vitamin A and B2 concentrations were significantly lower than in 34 healthy women (control group). No differences were noted in vitamin D, E, and B6 concentrations between groups. Moreover, HT patients had similar anthropometric parameters, lipid profiles, and glucose and insulin concentrations compared to controls. This study showed some relationships between vitamin concentrations and anthropometric or biochemical profiles in HT patients. Among others, in the HT group, the concentration of vitamin D was positively correlated with the level of HDL and negatively correlated with BMI, total fat mass, and insulin level, which influence cardiovascular risk. The results indicate that patients with HT should be routinely tested for vitamin concentrations to prevent nutritional deficiencies. Further studies are also needed on the role of vitamins in the development and progression of HT and the presence of metabolic complications in this population.

nutrition & dietetics
Concurrent engineering: basis and implementation

B. Bowonder,K. J. Sharma

DOI: https://doi.org/10.1504/IJMTM.2004.005386

2004-10-04

Abstract:Managing product development cycle time has been one of the critical competencies needed for meeting the competition. Using a series of approaches the product development process has been made concurrent. Overlapping phases of development involves intense interactions among team members, cross-functional teaming, use of information technology enablers and frequent reviews among team members, customers and suppliers. Taking up product development along with manufacturing process specifications improves manufacturability as well as assemblability. Many firms, including automobile firms and aerospace manufacturers have been able to reduce the product development cycle time along with the reduction in failure rates and rework. Enhancing horizontal interactions and early specification of deliverables facilitates coordination, paving the way for reducing time to market and product costs.
Assessment of the Correlation Between Vitamin D and T3, T4, FT3, FT4 and TSH Among Patients with Graves' Disease

Angham Jasim Mohammed Ali,Majedaldeen Jumaa Majeed Hamoud

DOI: https://doi.org/10.53350/pjmhs221651500

2022-05-30

Abstract:Background: Graves' disease is characterized by a diffuse hyperfunctional goiter that develops suddenly and is linked to an immune thyroid stimulating factor. Graves' disease hyperthyroidism is caused by circulating IgG antibodies binding to and activating the G-protein–coupled thyrotropin receptor. This activation causes thyroid enlargement by stimulating follicular hypertrophy and hyperplasia, as well as increases in thyroid hormone synthesis. Objectives: This study aims to assess the Determination the concentration of vitamin D in patients with graves diseases, Measurement T3, T4, FT3, FT4 and TSH hormones and Determination the correlation between immunological markers by the (SPSS). Materials and Methods: This research included a total of (90) people of various sexes and ages (30 men and 60 females), including (60) Graves' disease patients and (30) healthy people. Patients with Graves' disease were seen at Alsader Medical City (Najaf Center for Diabetes and Endocrinology). Between November 2021 and January 2022. Results: In this research, the levels of (T3, T4, TSH, FT3 and FT4) hormones and Vitamin D revealed a very significant association (P.value> 0.005) across the groups tested. A non-significant association was also found between vitamin D and other variables. According to the patients' group, the FT3 revealed a strong negative connection with vitamin D in comparison to the other parameters. Conclusion: The Thyrotropin receptor antibody (TRAb) test and ultrasonography of the thyroid gland are useful diagnostic tools for autoimmune Graves' disease. Grave's disease is connected with decreased vitamin D levels in the blood and could be made worse by high serum levels of T3, T4, FT3, FT4, and TRAb-positive and a low serum level of TSH.

English Else
Relationship between thyroid-stimulating hormone levels and the severity of vitamin D deficiency by age group

Mansi Modi,Pinky Garg

DOI: https://doi.org/10.5653/cerm.2023.06779

2024-08-19

Abstract:Objective: Researchers have long been captivated by the complex molecular interactions between vitamin D and the thyroid gland. Hypothyroidism affects 2% to 4% of women of reproductive age and can impact fertility through anovulatory cycles, luteal phase defects, hyperprolactinemia, and sex hormone imbalances. This study investigated the relationship between thyroid disease and the severity of vitamin D deficiency across different age groups. Methods: A retrospective study was conducted of 286 patient samples from individuals aged 18 to 60 years who were processed in the clinical biochemistry laboratory of our hospital. Samples were tested for thyroid-stimulating hormone (TSH) and vitamin D (specifically, vitamin D3) levels. The study samples were categorized into four clinically relevant groups based on TSH levels and into three groups based on serum 25-hydroxyvitamin D (25(OH)D) levels. Results: Most of the samples were from female patients (n=269), and the most common age group was 18 to 35 years (n=191, 66.78%). Subclinical hypothyroidism was identified in 120 patients, while vitamin D deficiency was present in 237 (82.87%) participants. A significant association was observed between vitamin D deficiency and the presence of thyroid disorders. Additionally, a significant negative correlation was found between TSH and vitamin D levels. Polycystic ovary syndrome was noted in 103 female patients (36.01%). Conclusion: TSH and 25(OH)D levels should be screened in all women of reproductive age, not just those in high-risk groups, as subclinical and occult hypothyroidism may otherwise go undiagnosed. Furthermore, TSH should be considered the primary screening test.
[Platelets and erectile dysfunction].

R. Jiang,H. Long

2015-09-01

Abstract:Platelets, small pieces of cytoplasm with biological activity, split and fall off the megakaryocytes and mature from the bone marrow. After stimulated, platelets produce nitric oxide to inhibit their own activation and aggregation. Pathologically, the injury of endothelial cells activates platelets and changes their functions. The release of inflammatory mediators and cytokines induces and enhances the development and progression of atherosclerosis, and thereby promotes the occurrence of erectile dysfunction. Besides, platelets and their related functional parameters may serve as important indicators in the diagnosis and treatment of erectile dysfunction.
Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto's thyroiditis: A systematic review and meta-analysis

Jiahao Tang,Shuanghong Shan,Fangping Li,Peng Yun

DOI: https://doi.org/10.1097/md.0000000000036759

IF: 1.6

2024-01-10

Medicine

Abstract:Hashimoto's thyroiditis (HT) is the prevailing form of autoimmune thyroiditis and the leading cause of hypothyroidism in iodine-sufficient regions worldwide. [ 1 ] The etiology of HT remains uncertain but is currently attributed to genetic susceptibility and environmental factors, including excessive iodine intake, selenium deficiency, viral infections (such as hepatitis C virus), vitamin D deficiency, and others. [ 1–3 ]

medicine, general & internal
Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis

Fen Feng,Bin Zhou,Ci-La Zhou,Ping Huang,Gang Wang,Kuang Yao

DOI: https://doi.org/10.4239/wjd.v15.i2.209

2024-02-05

World Journal of Diabetes

Abstract:BACKGROUND Diabetes and thyroiditis are closely related. They occur in combination and cause significant damage to the body. There is no clear treatment for type-2 diabetes mellitus (T2DM) with Hashimoto's thyroiditis (HT). While single symptomatic drug treatment of the two diseases is less effective, combined drug treatment may improve efficacy. AIM To investigate the effect of a combination of vitamin D, selenium, and hypo-glycemic agents in T2DM with HT. METHODS This retrospective study included 150 patients with T2DM and HT treated at The Central Hospital of Shaoyang from March 2020 to February 2023. Fifty patients were assigned to the control group, test group A, and test group B according to different treatment methods. The control group received low-iodine diet guidance and hypoglycemic drug treatment. Test group A received the control treatment plus vitamin D treatment. Test group B received the group A treatment plus selenium. Blood levels of markers of thyroid function [free T3 (FT3), thyroid stimulating hormone (TSH), free T4 (FT4)], autoantibodies [thyroid peroxidase antibody (TPOAB) and thyroid globulin antibody (TGAB)], blood lipid index [low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triacylglycerol (TG)], blood glucose index [fasting blood glucose (FBG), and hemoglobin A1c (HbA1c)] were measured pre-treatment and 3 and 6 months after treatment. The relationships between serum 25-hydroxyvitamin D3 [25 (OH) D3] level and each of these indices were analyzed. RESULTS The levels of 25 (OH) D3, FT3, FT4, and LDL-C increased in the order of the control group, test group A, and test group B (all P < 0.05). The TPOAB, TGAB, TC, TG, FBG, HbA1c, and TSH levels increased in the order of test groups B, A, and the control group (all P 0.05). The 25 (OH) D3 levels in test groups A and B were negatively correlated with FT4 and TGAB (all P < 0.05). CONCLUSION The combination drug treatment for T2DM with HT significantly improved thyroid function, autoantibody, and blood glucose and lipid levels.

endocrinology & metabolism
Clinical comparative efficacy and therapeutic strategies for the Hashimoto's thyroiditis: A systematic review and network meta-analysis

Jinli Luo,Ling Zhou,Aru Sun,Ye Min,Yiqun Lin,Lin Han

DOI: https://doi.org/10.1016/j.heliyon.2024.e35114

IF: 3.776

2024-07-31

Heliyon

Abstract:Ethnopharmacological relevance: Vitamin D (VD), selenium preparations (Se), and thyroid hormone replacement therapy are commonly used to treat Hashimoto thyroiditis (HT). Increasing evidence suggests that traditional Chinese medicine (TCM) is an effective therapeutic strategy in the treatment of HT. Aim of the study: This study aimed to investigate the efficacy and safety of commonly-used drugs for HT. Materials and methods: A literature search was performed using PubMed, Web of Science, Cochrane Library, EMBASE, Chinese China National Knowledge Infrastructure (CNKI), Clinical Trial Registry (Chi CTR), China Science and Technology Journal Database (the VIP), Wanfang Database, and China Chinese Biomedical Database (CBM) from January 1, 2003, to December 31, 2022. The outcomes included TPOAb, TgAb, TSH, FT3, FT4, and adverse events. Our study was registered in PROSPERO (CRD42023449705). Results: Sixty trials and 4719 participants were included, comparing 16 treatments: VD, Se, LT-4, Se + LT-4, HM, placebo + LT-4, HM + LT-4, Se + myolnositol, Se + VD, HM + Se, mannan peptide, LT-4+prednisone, Methimazole, Methimazole + HM, Tapazole + Propranolol, and placebo. We found that Chinese herbal medicine has significant effect vs. LT-4 [MD 0.10, 95 % confidence interval 0.02 to 0.50]) and LT-4+placebo [MD 0.10, 95 % confidence interval 0.01 to 0.77]) in reducing TPOAb. Although receiving LT-4+prednisone was not statistically significant, the treatment ranking showed that this combination therapy had the highest probability of reducing TPOAb levels (72.8 %). In addition, the effect of Se plus LT-4 was not statistically significant; however, the treatment ranking showed that this combination therapy had the highest probability (78.6 %) of reducing TgAb levels, followed by HM (64.0 %). Reports on side effects have mainly focused on the digestive and cardiovascular systems. Conclusion: Our analyses showed that HM alone or in combination with other treatments for patients with HT can improve the side effects of other drugs, enhance efficacy, and maybe the most effective option for treating HT. However, there still need further verified using high-quality evidence.
[Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].

T. Allhoff,F. Lenhart

1993-12-01

Abstract:Dextran-60 is widely used as a colloid volume substitute and for thromboprophylaxis. In order to avoid the most dangerous complication associated with dextran, the dextran-induced anaphylactic/anaphylactoid reaction (DIAR), hapten dextran is infused before starting the first application of dextran. We report of a 60-year-old man with multiple trauma, who received a dextran infusion for thromboprophylaxis because of high risk for thrombosis due to a severe thrombocytosis developing in the late postoperative period. Despite prophylaxis with monovalent hapten dextran, an anaphylactic reaction occurred. Although a serum sample drawn prior to the reaction is lacking, the causal relationship to dextran can be classified as likely, due to the close time relationship to the dextran-60 infusion. In addition, there were high titers of dextran-reactive antibodies in the blood drawn immediately after the reaction occurred. It is concluded that even after correct application of monovalent hapten dextran, dextran infusions carry the risk of severe anaphylactic reactions. They should therefore only be administered if clinical observation of the patient and the possibility of resuscitation are guaranteed.
Vitamin D deficiency is associated with thyroid diseases

S Jubair,A S Nsaif,A H Abdullah,I H Dhefer

DOI: https://doi.org/10.1088/1742-6596/1853/1/012036

2021-03-01

Journal of Physics: Conference Series

Abstract:Abstract Background The deficiency of vitamin D3 (VD) is a universal health issue, its role in different kind of diseases is being studied recently. However, its role in thyroid diseases is not well established yet. This study aims to determine the impact of VD in the pathogenesis of hypothyroidism and hyperthyroidism. Method. Three hundred Iraqi females with age ranged between 30 and 55 years participate in this research, 100 of them were hypothyroid patients, 100 females were hyperthyroid patients and the other 100 females were healthy volunteers served as controls. Thyroid hormones, VD, liver function parameters, and kidney function parameters were determined using different analysis techniques. Results. The levels of VD were significantly decreased in both hypothyroid and hyperthyroid patients (19.644 ± 10.524 for hypothyroid patients and 22.712 ± 11.249 for hyperthyroid patients vs. 30.880 ± 2.587 for controls, p <0.0001). Liver function parameters were within the normal ranges in all the patients. Creatinine and uric acid were within the normal ranges, while urea was significantly increased and out of the normal clinical range in both hypothyroid and hyperthyroid patients (39.560 ± 9.912 for hypothyroidism patients and 42.460 ±7.171 for hyperthyroid patients vs. 26.920 ± 5.033 for controls, p <0.0001). Conclusion. Vitamin D3 and kidney function tests must be included in the differential detection of thyroid diseases. Still, further investigations are needed to understand the underlying mechanism by which VD affects thyroid hormone regulation.
The role of serum inflammatory factors in predicting treatment response in patients with vitiligo and concomitant Hashimoto's thyroiditis

Xuwen Yin,Lei Shi,Heng Li,Jianwen Long

DOI: https://doi.org/10.5114/ada.2024.142287

Abstract:Introduction: Vitiligo (VL) is associated with several autoimmune diseases, especially Hashimoto's thyroiditis, VL and concomitant Hashimoto's thyroiditis (HT) up to 34% in VL. Aim: To assess the predictive value of serum inflammatory factors in guiding treatment response among patients with concurrent VL and concomitant HT. Material and methods: This retrospective study enrolled 67 cases of VL and concomitant HT, and the patients according to treatment outcomes were divided into the unsatisfied group and the satisfied group. The serum thyroid parameters, autoimmune markers, and inflammatory factor levels were analysed and the correlation analysis of serum inflammatory factors was made. Results: The study analysis of serum thyroid parameters showed elevated levels of thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), thyroperoxidase (TPO), and thyroglobulin (Tg) (p < 0.05) in the group with unsatisfactory treatment response. Patients in the unsatisfied group exhibited elevated inflammatory factor levels of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10) (p < 0.05) compared to their counterparts in the satisfied group. Correlation analysis showed that the levels of the above inflammatory factors were significantly negatively correlated with the treatment response. Conclusions: CRP, TNF-α, IL-6, IL-8, IL-10 showed the strongest correlation with VL and concomitant HT, and serum inflammatory factors levels can predict treatment response in patients with VL and concomitant HT.
The Effects of Vitamin D and Gene Polymorphisms on Susceptibility to Thyroid Peroxidase Antibody Positivity

Jing Cheng,Lin Ye,Yingchao Chen,Bing Han,Ningjian Wang,Qin Li,Yingli Lu

DOI: https://doi.org/10.1016/j.amjms.2024.06.014

IF: 3.462

2024-06-27

The American Journal of the Medical Sciences

Abstract:Background The etiology of Hashimoto's thyroiditis (HT) involves genetic and environmental factors. There is a lack of clarity regarding the relationship between Vitamin D and HT. This study aimed to investigate the effect of Vitamin D and gene polymorphisms on thyroid peroxidase antibody (TPOAb) positivity. Methods A total of 9,966 participants were included from a survey conducted in East China from 2014 to 2016. We measured the levels of 25(OH)D, thyroid hormones and autoimmune antibodies. rs11675434, rs9277555, and rs301799 were genotyped. Based on these 3 SNPs, a weighted genetic risk score was calculated for TPOAb. Results The proportion of females in the TPOAb-positive group was greater than that in the TPOAb-negative group (74.2% vs. 57.2%, P<0.001). Vitamin D levels were lower in the TPOAb-positive group than in the TPOAb-negative group (40.07±11.87 vs. 40.80±12.84, P=0.01). The GG genotype of rs9277555 and the TT genotype of rs11675434 were correlated with the risk of TPOAb positivity (OR=1.34, 95% CI 1.13-1.59, P=0.001; OR=1.29, 95% CI 1.06-1.58, P=0.01). TPOAb-GRS was associated with TPOAb positivity (OR=3.17, 95% CI 1.72-5.84; P<0.001). When stratified by Vitamin D group, the association between TPOAb-GRS and TPOAb positivity existed only in the Vitamin D deficiency group (OR=3.41, 95% CI 1.73-6.70 P<0.001) but not in the control group (OR=2.45, 95% CI 0.59-10.19, P=0.22). Conclusions This study suggested that TPOAb-GRS was associated with TPOAb positivity in the Han Chinese population, mainly due to rs9277555 and rs11675434. The hereditary effect of TPOAb positivity differed depending on Vitamin D status.

medicine, general & internal

S1-nuclease mapping of the genomic Lepore-Boston DNA demonstrates that the entire large intervening sequence of the fusion gene is of beta-type.

Correlation Between Hashimoto's Thyroiditis–Related Thyroid Hormone Levels and 25-Hydroxyvitamin D

Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto’s Thyroiditis? A Double Blind, Randomized Clinical Trial

Clinical Efficacy and Mechanism of Vitamin D2 in Treating Hashimoto's Thyroiditis

Association of vitamin D and inflammatory biomarkers with newly diagnosed cases of hypothyroidism- A case-control study

The Effect of Vitamin D Supplementation on Thyroid Hormone Levels in Patients With Autoimmune Thyroid Disease: A Systematic Review

Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey

Alterations in CD4+ T Cell Cytokines Profile in Female Patients with Hashimoto’s Thyroiditis Following Vitamin D Supplementation: A Double-blind, Randomized Clinical Trial

Autoimmune Thyroiditis and Vitamin D

Assessment of Vitamin Concentrations in Patients with Hashimoto's Thyroiditis and Their Relationships with Thyroid Function, Biochemical Status, and Anthropometric Parameters—A Preliminary Study

Concurrent engineering: basis and implementation

Assessment of the Correlation Between Vitamin D and T3, T4, FT3, FT4 and TSH Among Patients with Graves' Disease

Relationship between thyroid-stimulating hormone levels and the severity of vitamin D deficiency by age group

[Platelets and erectile dysfunction].

Effects of vitamin D supplementation on autoantibodies and thyroid function in patients with Hashimoto's thyroiditis: A systematic review and meta-analysis

Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis

Clinical comparative efficacy and therapeutic strategies for the Hashimoto's thyroiditis: A systematic review and network meta-analysis

[Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].

Vitamin D deficiency is associated with thyroid diseases

The role of serum inflammatory factors in predicting treatment response in patients with vitiligo and concomitant Hashimoto's thyroiditis

The Effects of Vitamin D and Gene Polymorphisms on Susceptibility to Thyroid Peroxidase Antibody Positivity